Perales MA - Search Results

1

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, Manukian G, Wang J, Zhang Y, Chapman PB, Krown SE, Livingston PO, Ejadi S, Panageas KS, Engelhorn ME, Terzulli SL, Houghton AN, Wolchok JD. Perales MA, et al. Mol Ther. 2008 Dec;16(12):2022-9. doi: 10.1038/mt.2008.196. Epub 2008 Sep 16. Mol Ther. 2008. PMID: 18797450 Free PMC article. Clinical Trial.

2

Strategies to overcome immune ignorance and tolerance.

Perales MA, Blachere NE, Engelhorn ME, Ferrone CR, Gold JS, Gregor PD, Noffz G, Wolchok JD, Houghton AN. Perales MA, et al. Semin Cancer Biol. 2002 Feb;12(1):63-71. doi: 10.1006/scbi.2001.0397. Semin Cancer Biol. 2002. PMID: 11926414 Review.

3

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo.

Trcka J, Moroi Y, Clynes RA, Goldberg SM, Bergtold A, Perales MA, Ma M, Ferrone CR, Carroll MC, Ravetch JV, Houghton AN. Trcka J, et al. Among authors: ma m, perales ma. Immunity. 2002 Jun;16(6):861-8. doi: 10.1016/s1074-7613(02)00327-8. Immunity. 2002. PMID: 12121667 Free article.

4

Melanoma vaccines.

Perales MA, Wolchok JD. Perales MA, et al. Cancer Invest. 2002;20(7-8):1012-26. doi: 10.1081/cnv-120005918. Cancer Invest. 2002. PMID: 12449735 Review.

5

Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.

Wolchok JD, Srinivasan R, Perales MA, Houghton AN, Bowne WB, Blachere NE. Wolchok JD, et al. Among authors: perales ma. Cancer Immun. 2001 Aug 16;1:9. Cancer Immun. 2001. PMID: 12747770

6

GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines.

Perales MA, Fantuzzi G, Goldberg SM, Turk MJ, Mortazavi F, Busam K, Houghton AN, Dinarello CA, Wolchok JD. Perales MA, et al. Cytokines Cell Mol Ther. 2002;7(3):125-33. doi: 10.1080/13684730310000923. Cytokines Cell Mol Ther. 2002. PMID: 12850812

7

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems.

Gregor PD, Wolchok JD, Ferrone CR, Buchinshky H, Guevara-Patiño JA, Perales MA, Mortazavi F, Bacich D, Heston W, Latouche JB, Sadelain M, Allison JP, Scher HI, Houghton AN. Gregor PD, et al. Among authors: perales ma. Vaccine. 2004 Apr 16;22(13-14):1700-8. doi: 10.1016/j.vaccine.2003.10.048. Vaccine. 2004. PMID: 15068853

8

Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.

Chang DZ, Lomazow W, Joy Somberg C, Stan R, Perales MA. Chang DZ, et al. Among authors: perales ma. Hematology. 2004 Jun;9(3):207-15. doi: 10.1080/10245330410001701549. Hematology. 2004. PMID: 15204102 Free article. Review.

9

CD4 help and tumor immunity: beyond the activation of cytotoxic T lymphocytes.

Perales MA, Wolchok JD. Perales MA, et al. Ann Surg Oncol. 2004 Oct;11(10):881-2. doi: 10.1245/ASO.2004.08.911. Epub 2004 Sep 20. Ann Surg Oncol. 2004. PMID: 15383423 No abstract available.

10

Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

Perales MA, Chapman PB. Perales MA, et al. Cancer Chemother Biol Response Modif. 2005;22:749-60. doi: 10.1016/s0921-4410(04)22034-8. Cancer Chemother Biol Response Modif. 2005. PMID: 16110638 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters